- Doctors & Departments
- Conditions & Advice
- Your Visit
- Research & Innovation
At the Center for Cancer and Blood Disorders, discoveries from our laboratories are changing the way care is delivered for pediatric hematology, oncology and bone marrow transplants.
Our scientists are recognized as national leaders in basic and clinical science research and have funding to support their research from numerous national hematology and oncology foundations.
More than anything else on the medical horizon, CAR-T cell therapy stands poised to alter cancer treatment. But it's not there yet.
The goal of the study is to identify biologically rational therapeutics for the medical treatment of adamantinomatous craniopharyngioma by confirming the overexpression of specific molecules and ultimately improving treatment for patients with this rare tumor.
We believe that state-of-the-art treatment for pediatric cancer and blood disorders typically includes enrollment in a clinical trial. In fact, research shows that children who participate in clinical trials have better survival rates than children who do not.
Our physicians and nurses collaborate with laboratory researchers to find new cures and better cancer treatment. Some of our team's most significant advancements include:
"Treatment for autoimmune diseases involves manipulating the same cells we're manipulating for cancer treatment."
Terry J. Fry, MD, pediatric hematologist
Director of Cancer ImmunotherapyLearn about Dr. Fry's research
Physicians at the Center for Cancer and Blood Disorders have a variety of interests in clinical, translational and laboratory research. Our major focus areas include:
Our translational and basic laboratory research includes:
Our faculty collaborates with international consortiums, laboratory researchers and the University of Colorado Cancer Center to find new cures and better cancer treatments for children.
We also participate in every major pediatric cooperative group for cancer and blood disorders, including:
Learn more about the Center for Cancer and Blood Disorders.